Sources | Names Used |
---|---|
CTRPv2 | selumetinib:BRD-A02303741 (4:1 mol/mol) |
PharmacoGx | selumetinib:BRD-A02303741 (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TMEM105 | CTRPv2 | pan-cancer | AAC | 0.23 | 9e-11 |
mRNA | PRPS1 | CTRPv2 | pan-cancer | AAC | -0.23 | 1e-10 |
mRNA | SPRY4 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-10 |
mRNA | MYO1F | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-10 |
mRNA | GPX1 | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-10 |
mRNA | ACY1 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-10 |
mRNA | ARAP3 | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-10 |
mRNA | MYO15B | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-10 |
mRNA | LPCAT2 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
mRNA | C16orf87 | CTRPv2 | pan-cancer | AAC | -0.22 | 1e-09 |